Foreign body reaction: towards a macrophage-centered adverse outcome pathway for fibrotic encapsulation.

ABSTRACT: The foreign body reaction (FBR), characterized by chronic inflammation and fibrotic capsule formation around implanted medical devices, remains a major cause in device-related complications. Current preclinical risk assessment relies on in vivo testing according to ISO 10993-6:2024, which are limited by species differences, incomplete mechanistic insight, and ethical concerns. Additionally, ISO/TS 10993-20:2006 outlines immunotoxicity knowledge regarding implant-induced effects such as FBR and specifies a collection of in vitro assays. The perspective presented here, aims to explore the applicability of the Adverse Outcome Pathway (AOP) framework to FBR in order to integrate evidence and methods into a structured mechanistic context and facilitate the application of in vit

SUBMITTER: Meseberg T 

PROVIDER: S-EPMC12912714 | biostudies-literature | 2026

REPOSITORIES: biostudies-literature